Corrigendum to "Second line treatment with gemcitabine and vinorelbine in non-small-cell lung cancer (NSCLC) cisplatin failures: a pilot study".
Camps
C
Hospital General Universitario de Valencia, Valencia, Spain.
Nogueron Martinez E
Berrocal Jaime A